Discovery and development of integrase inhibitors

Results: 6



#Item
1June 17, 2009   Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

June 17, 2009  Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

Add to Reading List

Source URL: www.csb.pitt.edu

Language: English - Date: 2013-11-27 16:23:21
2HIV-1 RT p51 subunit Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

HIV-1 RT p51 subunit Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

Add to Reading List

Source URL: www.jenabioscience.com

Language: English - Date: 2014-04-14 05:57:26
3HIV-1 RT heterodimer Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

HIV-1 RT heterodimer Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

Add to Reading List

Source URL: www.jenabioscience.com

Language: English - Date: 2014-04-14 05:57:18
4AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 106

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 106

Add to Reading List

Source URL: aidsinfonet.org

Language: English - Date: 2014-04-21 15:36:33
5Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013

Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
6Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products March 4, 2013

Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products March 4, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English